

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitotic chromosome condensation (GO:0007076) | 4.77805384 |
| 2 | immunoglobulin mediated immune response (GO:0016064) | 4.32312292 |
| 3 | regulation of female gonad development (GO:2000194) | 4.17298099 |
| 4 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.02630102 |
| 5 | protein K6-linked ubiquitination (GO:0085020) | 3.91854759 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 3.66861265 |
| 7 | piRNA metabolic process (GO:0034587) | 3.64551904 |
| 8 | regulation of histone H3-K27 methylation (GO:0061085) | 3.58756432 |
| 9 | B cell mediated immunity (GO:0019724) | 3.56190138 |
| 10 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.53620331 |
| 11 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 3.52667735 |
| 12 | mitotic sister chromatid cohesion (GO:0007064) | 3.51199180 |
| 13 | regulation of chronic inflammatory response (GO:0002676) | 3.50193272 |
| 14 | regulation of meiosis (GO:0040020) | 3.48405191 |
| 15 | regulation of sister chromatid cohesion (GO:0007063) | 3.47527096 |
| 16 | mitotic metaphase plate congression (GO:0007080) | 3.36150178 |
| 17 | notochord development (GO:0030903) | 3.33231269 |
| 18 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.29226630 |
| 19 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.27872980 |
| 20 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.26738077 |
| 21 | regulation of podosome assembly (GO:0071801) | 3.26360707 |
| 22 | positive regulation of megakaryocyte differentiation (GO:0045654) | 3.24813584 |
| 23 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.20839107 |
| 24 | response to peptidoglycan (GO:0032494) | 3.19952833 |
| 25 | female gamete generation (GO:0007292) | 3.19663750 |
| 26 | meiotic cell cycle (GO:0051321) | 3.19140724 |
| 27 | meiotic chromosome segregation (GO:0045132) | 3.18550411 |
| 28 | response to interferon-beta (GO:0035456) | 3.18049781 |
| 29 | regulation of mononuclear cell migration (GO:0071675) | 3.15696310 |
| 30 | positive regulation of antigen processing and presentation (GO:0002579) | 3.15065091 |
| 31 | histone H2A monoubiquitination (GO:0035518) | 3.11986412 |
| 32 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.10361892 |
| 33 | negative regulation of meiosis (GO:0045835) | 3.09604764 |
| 34 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.08654840 |
| 35 | DNA damage induced protein phosphorylation (GO:0006975) | 3.07890599 |
| 36 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.06968414 |
| 37 | regulation of antigen processing and presentation (GO:0002577) | 3.06674754 |
| 38 | viral transcription (GO:0019083) | 3.02514425 |
| 39 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.02323324 |
| 40 | regulation of chemokine biosynthetic process (GO:0045073) | 3.00715623 |
| 41 | T-helper 1 type immune response (GO:0042088) | 3.00480114 |
| 42 | protein localization to chromosome, centromeric region (GO:0071459) | 3.00447443 |
| 43 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 3.00243119 |
| 44 | metaphase plate congression (GO:0051310) | 2.99825691 |
| 45 | macrophage activation involved in immune response (GO:0002281) | 2.99388538 |
| 46 | cellular response to type I interferon (GO:0071357) | 2.99157096 |
| 47 | type I interferon signaling pathway (GO:0060337) | 2.99157096 |
| 48 | granulocyte activation (GO:0036230) | 2.99103848 |
| 49 | eosinophil chemotaxis (GO:0048245) | 2.96193138 |
| 50 | DNA deamination (GO:0045006) | 2.95978463 |
| 51 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.95201617 |
| 52 | mitotic sister chromatid segregation (GO:0000070) | 2.94759750 |
| 53 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.94610955 |
| 54 | response to type I interferon (GO:0034340) | 2.93975999 |
| 55 | mitotic nuclear envelope disassembly (GO:0007077) | 2.93730315 |
| 56 | translational termination (GO:0006415) | 2.93608432 |
| 57 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.93230290 |
| 58 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.93219878 |
| 59 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.92856882 |
| 60 | gene silencing by RNA (GO:0031047) | 2.92473977 |
| 61 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.91721971 |
| 62 | myoblast migration (GO:0051451) | 2.86263594 |
| 63 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 2.84554589 |
| 64 | positive regulation of granulocyte differentiation (GO:0030854) | 2.84524409 |
| 65 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.83718655 |
| 66 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.83696632 |
| 67 | regulation of interferon-alpha production (GO:0032647) | 2.83663919 |
| 68 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.83204388 |
| 69 | defense response to protozoan (GO:0042832) | 2.82528762 |
| 70 | paraxial mesoderm development (GO:0048339) | 2.82002309 |
| 71 | establishment of chromosome localization (GO:0051303) | 2.79534502 |
| 72 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.79069911 |
| 73 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.77885148 |
| 74 | regulation of proton transport (GO:0010155) | 2.77520114 |
| 75 | cytidine metabolic process (GO:0046087) | 2.76601354 |
| 76 | cytidine catabolic process (GO:0006216) | 2.76601354 |
| 77 | cytidine deamination (GO:0009972) | 2.76601354 |
| 78 | cellular response to interferon-gamma (GO:0071346) | 2.76301053 |
| 79 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.75906545 |
| 80 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 2.75822778 |
| 81 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.75128106 |
| 82 | neutrophil activation (GO:0042119) | 2.74970009 |
| 83 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.73607606 |
| 84 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.73138230 |
| 85 | regulation of growth of symbiont in host (GO:0044126) | 2.73138230 |
| 86 | negative regulation of growth of symbiont in host (GO:0044130) | 2.73138230 |
| 87 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.73138230 |
| 88 | regulation of interleukin-12 production (GO:0032655) | 2.72694535 |
| 89 | regulation of exit from mitosis (GO:0007096) | 2.72440823 |
| 90 | response to interferon-gamma (GO:0034341) | 2.72011514 |
| 91 | positive regulation by symbiont of host defense response (GO:0052509) | 2.69390742 |
| 92 | modulation by symbiont of host defense response (GO:0052031) | 2.69390742 |
| 93 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.69390742 |
| 94 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.69390742 |
| 95 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.69390742 |
| 96 | modulation by symbiont of host immune response (GO:0052553) | 2.69390742 |
| 97 | positive regulation of interleukin-12 production (GO:0032735) | 2.67950624 |
| 98 | positive thymic T cell selection (GO:0045059) | 2.67841366 |
| 99 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.67834607 |
| 100 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.66856745 |
| 101 | lymphocyte chemotaxis (GO:0048247) | 2.66048332 |
| 102 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 2.65517189 |
| 103 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.65408983 |
| 104 | nuclear envelope disassembly (GO:0051081) | 2.64913820 |
| 105 | membrane disassembly (GO:0030397) | 2.64913820 |
| 106 | sister chromatid cohesion (GO:0007062) | 2.64763448 |
| 107 | indole-containing compound catabolic process (GO:0042436) | 2.64521170 |
| 108 | indolalkylamine catabolic process (GO:0046218) | 2.64521170 |
| 109 | tryptophan catabolic process (GO:0006569) | 2.64521170 |
| 110 | folic acid metabolic process (GO:0046655) | 2.64327820 |
| 111 | regulation of vitamin metabolic process (GO:0030656) | 2.64051119 |
| 112 | one-carbon metabolic process (GO:0006730) | 2.63737850 |
| 113 | detection of other organism (GO:0098543) | 2.63448107 |
| 114 | regulation of T cell tolerance induction (GO:0002664) | 2.63351187 |
| 115 | eosinophil migration (GO:0072677) | 2.63003284 |
| 116 | myeloid dendritic cell differentiation (GO:0043011) | 2.61880868 |
| 117 | respiratory burst (GO:0045730) | 2.61860580 |
| 118 | ribosomal small subunit biogenesis (GO:0042274) | 2.61572960 |
| 119 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.61519308 |
| 120 | oligosaccharide catabolic process (GO:0009313) | 2.60851161 |
| 121 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.59196631 |
| 122 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.59099717 |
| 123 | positive regulation of mast cell degranulation (GO:0043306) | 2.59099717 |
| 124 | myeloid dendritic cell activation (GO:0001773) | 2.58861448 |
| 125 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.58843198 |
| 126 | ATP synthesis coupled proton transport (GO:0015986) | 2.58843198 |
| 127 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.58771436 |
| 128 | translational elongation (GO:0006414) | 2.58513270 |
| 129 | response to protozoan (GO:0001562) | 2.58303130 |
| 130 | cellular response to interferon-beta (GO:0035458) | 2.58249875 |
| 131 | detection of bacterium (GO:0016045) | 2.58136552 |
| 132 | negative regulation of viral genome replication (GO:0045071) | 2.57927316 |
| 133 | kinetochore organization (GO:0051383) | 2.57376098 |
| 134 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.57318107 |
| 135 | negative regulation of histone methylation (GO:0031061) | 2.56610738 |
| 136 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.56531038 |
| 137 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.56531038 |
| 138 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.55139548 |
| 139 | monocyte chemotaxis (GO:0002548) | 2.54599945 |
| 140 | protein localization to kinetochore (GO:0034501) | 2.54321513 |
| 141 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.53976174 |
| 142 | regulation of meiosis I (GO:0060631) | 2.53934913 |
| 143 | myeloid cell activation involved in immune response (GO:0002275) | 2.53153449 |
| 144 | regulation of meiotic cell cycle (GO:0051445) | 2.53085247 |
| 145 | male meiosis (GO:0007140) | 2.51261720 |
| 146 | positive regulation of mast cell activation (GO:0033005) | 2.51075757 |
| 147 | chromosome condensation (GO:0030261) | 2.50148212 |
| 148 | positive regulation of prostaglandin secretion (GO:0032308) | 2.49802360 |
| 149 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.49466713 |
| 150 | positive regulation of interferon-alpha production (GO:0032727) | 2.49371995 |
| 151 | glycosphingolipid catabolic process (GO:0046479) | 2.48957988 |
| 152 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.48676882 |
| 153 | kinetochore assembly (GO:0051382) | 2.48459443 |
| 154 | sister chromatid segregation (GO:0000819) | 2.48449867 |
| 155 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.48381557 |
| 156 | histone H2A ubiquitination (GO:0033522) | 2.48182054 |
| 157 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.47929329 |
| 158 | chromatin assembly or disassembly (GO:0006333) | 2.47716748 |
| 159 | drug catabolic process (GO:0042737) | 2.47620092 |
| 160 | chromatin remodeling at centromere (GO:0031055) | 2.46958312 |
| 161 | kynurenine metabolic process (GO:0070189) | 2.46389044 |
| 162 | dendritic cell chemotaxis (GO:0002407) | 2.45924221 |
| 163 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.45370721 |
| 164 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.45341696 |
| 165 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.45239520 |
| 166 | negative regulation of cell killing (GO:0031342) | 2.45239520 |
| 167 | NIK/NF-kappaB signaling (GO:0038061) | 2.44588913 |
| 168 | positive regulation of interferon-gamma production (GO:0032729) | 2.44454538 |
| 169 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.43968841 |
| 170 | protein complex localization (GO:0031503) | 2.43758713 |
| 171 | RNA stabilization (GO:0043489) | 2.43313013 |
| 172 | mRNA stabilization (GO:0048255) | 2.43313013 |
| 173 | regulation of hippo signaling (GO:0035330) | 2.42745400 |
| 174 | maturation of 5.8S rRNA (GO:0000460) | 2.42644190 |
| 175 | DNA replication-independent nucleosome organization (GO:0034724) | 2.41911976 |
| 176 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.41911976 |
| 177 | type B pancreatic cell development (GO:0003323) | 2.41428173 |
| 178 | endothelial tube morphogenesis (GO:0061154) | 2.39665806 |
| 179 | morphogenesis of an endothelium (GO:0003159) | 2.39665806 |
| 180 | protein localization to chromosome (GO:0034502) | 2.39653210 |
| 181 | DNA replication checkpoint (GO:0000076) | 2.39433869 |
| 182 | CENP-A containing nucleosome assembly (GO:0034080) | 2.38096444 |
| 183 | translational initiation (GO:0006413) | 2.36732101 |
| 184 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.35084372 |
| 185 | intestinal epithelial cell development (GO:0060576) | 2.32792977 |
| 186 | regulation of RNA stability (GO:0043487) | 2.32787086 |
| 187 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.32584486 |
| 188 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.30958237 |
| 189 | negative regulation of cell aging (GO:0090344) | 2.30129209 |
| 190 | citrulline biosynthetic process (GO:0019240) | 2.29961333 |
| 191 | regulation of RIG-I signaling pathway (GO:0039535) | 2.29893538 |
| 192 | T cell apoptotic process (GO:0070231) | 2.29708509 |
| 193 | chromosome segregation (GO:0007059) | 2.29642390 |
| 194 | negative regulation of interleukin-12 production (GO:0032695) | 2.28750111 |
| 195 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.28697024 |
| 196 | cysteine metabolic process (GO:0006534) | 2.28330957 |
| 197 | protein targeting to ER (GO:0045047) | 2.24218435 |
| 198 | regulation of cardioblast differentiation (GO:0051890) | 2.21490744 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.85621241 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 5.41618271 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.41070203 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.84847458 |
| 5 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 4.18158413 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.24742005 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.10303770 |
| 8 | AR_21909140_ChIP-Seq_LNCAP_Human | 3.08588135 |
| 9 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.00394084 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.89591407 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.86141440 |
| 12 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.71025661 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.68550093 |
| 14 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.65452549 |
| 15 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.65359876 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.62249954 |
| 17 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.44462954 |
| 18 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.41659096 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.40330971 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.37766665 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.23727051 |
| 22 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.15967681 |
| 23 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.14876892 |
| 24 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.14339080 |
| 25 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.10122621 |
| 26 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.06943330 |
| 27 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04706668 |
| 28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.02406925 |
| 29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.98081621 |
| 30 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.96997169 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.95304519 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.94730697 |
| 33 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.92096144 |
| 34 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.90981895 |
| 35 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.88023875 |
| 36 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.85879452 |
| 37 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.82639232 |
| 38 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.82295437 |
| 39 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79714065 |
| 40 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.79580907 |
| 41 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.75428838 |
| 42 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.74521565 |
| 43 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.72138309 |
| 44 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.72067837 |
| 45 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.68545162 |
| 46 | UTX_26944678_Chip-Seq_JUKART_Human | 1.67997197 |
| 47 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.66741516 |
| 48 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64680159 |
| 49 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.62433468 |
| 50 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.60127671 |
| 51 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.58172176 |
| 52 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.54522809 |
| 53 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.54472409 |
| 54 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.53169752 |
| 55 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.53028900 |
| 56 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.52066968 |
| 57 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.51872047 |
| 58 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.49309268 |
| 59 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.48510738 |
| 60 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.47968859 |
| 61 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.43422342 |
| 62 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.42987627 |
| 63 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.40572881 |
| 64 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.39787452 |
| 65 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.37119214 |
| 66 | MYB_26560356_Chip-Seq_TH2_Human | 1.36857457 |
| 67 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36498981 |
| 68 | GATA3_26560356_Chip-Seq_TH2_Human | 1.31400293 |
| 69 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30610235 |
| 70 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30114848 |
| 71 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.29328210 |
| 72 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.28547134 |
| 73 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.26777899 |
| 74 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.26376405 |
| 75 | MAF_26560356_Chip-Seq_TH1_Human | 1.24972579 |
| 76 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.24673905 |
| 77 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.24431032 |
| 78 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.23133467 |
| 79 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.22824986 |
| 80 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.22745151 |
| 81 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.22383970 |
| 82 | MYB_26560356_Chip-Seq_TH1_Human | 1.22081000 |
| 83 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.21359531 |
| 84 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.19685626 |
| 85 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19402782 |
| 86 | ATF3_27146783_Chip-Seq_COLON_Human | 1.19354828 |
| 87 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17813441 |
| 88 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17559450 |
| 89 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.17438809 |
| 90 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16610247 |
| 91 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.15775686 |
| 92 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.14521273 |
| 93 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.13767674 |
| 94 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13203119 |
| 95 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12854442 |
| 96 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12276820 |
| 97 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.11241587 |
| 98 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.10647902 |
| 99 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10529531 |
| 100 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10152868 |
| 101 | SPI1_23127762_ChIP-Seq_K562_Human | 1.09762711 |
| 102 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.09393696 |
| 103 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09143842 |
| 104 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.08506209 |
| 105 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08154032 |
| 106 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.08000027 |
| 107 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04749356 |
| 108 | MAF_26560356_Chip-Seq_TH2_Human | 1.04378326 |
| 109 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03822988 |
| 110 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.03444563 |
| 111 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.03382161 |
| 112 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.01270550 |
| 113 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.00903750 |
| 114 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.00392560 |
| 115 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.00151167 |
| 116 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00089228 |
| 117 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.99461376 |
| 118 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.99139535 |
| 119 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.98989054 |
| 120 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.97827900 |
| 121 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.97147303 |
| 122 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96489730 |
| 123 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96316935 |
| 124 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95607827 |
| 125 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.95148209 |
| 126 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.94990958 |
| 127 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94880246 |
| 128 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.93702858 |
| 129 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.93435239 |
| 130 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92748132 |
| 131 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.92235215 |
| 132 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.91837220 |
| 133 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.91043859 |
| 134 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89718063 |
| 135 | P300_27268052_Chip-Seq_Bcells_Human | 0.89537651 |
| 136 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.89371747 |
| 137 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.88867146 |
| 138 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.88831291 |
| 139 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.88457809 |
| 140 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.88328339 |
| 141 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.87607181 |
| 142 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.87565895 |
| 143 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.87134370 |
| 144 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.86453627 |
| 145 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.86418814 |
| 146 | SA1_27219007_Chip-Seq_Bcells_Human | 0.86196470 |
| 147 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85947990 |
| 148 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.85682748 |
| 149 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.85579939 |
| 150 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85257012 |
| 151 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.85144317 |
| 152 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.84863653 |
| 153 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.84310519 |
| 154 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.84078759 |
| 155 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83465809 |
| 156 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.81934916 |
| 157 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.79607616 |
| 158 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.79607616 |
| 159 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.79169482 |
| 160 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.78757451 |
| 161 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.77587730 |
| 162 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.77352205 |
| 163 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.77288560 |
| 164 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.76610678 |
| 165 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.75731734 |
| 166 | GATA3_26560356_Chip-Seq_TH1_Human | 0.75620398 |
| 167 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.75167553 |
| 168 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.74705461 |
| 169 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.73535602 |
| 170 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.73213871 |
| 171 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.72711455 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.89593331 |
| 2 | MP0009785_altered_susceptibility_to | 3.65165482 |
| 3 | MP0006082_CNS_inflammation | 3.45025563 |
| 4 | MP0005451_abnormal_body_composition | 3.42460060 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.38310699 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.32824215 |
| 7 | MP0003646_muscle_fatigue | 2.96246210 |
| 8 | MP0003718_maternal_effect | 2.80699396 |
| 9 | MP0003693_abnormal_embryo_hatching | 2.74516839 |
| 10 | MP0003436_decreased_susceptibility_to | 2.68578747 |
| 11 | MP0003195_calcinosis | 2.59525187 |
| 12 | MP0005025_abnormal_response_to | 2.54055382 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.50883287 |
| 14 | MP0005387_immune_system_phenotype | 2.47828308 |
| 15 | MP0001790_abnormal_immune_system | 2.47828308 |
| 16 | MP0002419_abnormal_innate_immunity | 2.47797810 |
| 17 | MP0004510_myositis | 2.26809539 |
| 18 | MP0002254_reproductive_system_inflammat | 2.26243450 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.25100631 |
| 20 | MP0002723_abnormal_immune_serum | 2.23623442 |
| 21 | MP0003763_abnormal_thymus_physiology | 2.22071804 |
| 22 | MP0005058_abnormal_lysosome_morphology | 2.21142795 |
| 23 | MP0010368_abnormal_lymphatic_system | 2.17373592 |
| 24 | MP0004957_abnormal_blastocyst_morpholog | 2.16798497 |
| 25 | MP0005360_urolithiasis | 2.12402585 |
| 26 | MP0009840_abnormal_foam_cell | 2.10441004 |
| 27 | MP0004185_abnormal_adipocyte_glucose | 2.05523726 |
| 28 | MP0001873_stomach_inflammation | 1.99447999 |
| 29 | MP0002139_abnormal_hepatobiliary_system | 1.99408098 |
| 30 | MP0002837_dystrophic_cardiac_calcinosis | 1.99190550 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.98287010 |
| 32 | MP0000490_abnormal_crypts_of | 1.93660615 |
| 33 | MP0000685_abnormal_immune_system | 1.92505663 |
| 34 | MP0001819_abnormal_immune_cell | 1.92346371 |
| 35 | MP0003075_altered_response_to | 1.91261869 |
| 36 | MP0003111_abnormal_nucleus_morphology | 1.91071014 |
| 37 | MP0002420_abnormal_adaptive_immunity | 1.90801516 |
| 38 | MP0005365_abnormal_bile_salt | 1.90582482 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.89193417 |
| 40 | MP0009764_decreased_sensitivity_to | 1.89097898 |
| 41 | MP0003077_abnormal_cell_cycle | 1.88868878 |
| 42 | MP0008469_abnormal_protein_level | 1.85873233 |
| 43 | MP0010094_abnormal_chromosome_stability | 1.78030806 |
| 44 | MP0003705_abnormal_hypodermis_morpholog | 1.72125755 |
| 45 | MP0002653_abnormal_ependyma_morphology | 1.68755946 |
| 46 | MP0003303_peritoneal_inflammation | 1.61435260 |
| 47 | MP0002396_abnormal_hematopoietic_system | 1.61190395 |
| 48 | MP0000343_altered_response_to | 1.59615493 |
| 49 | MP0004264_abnormal_extraembryonic_tissu | 1.58116420 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.55545704 |
| 51 | MP0003186_abnormal_redox_activity | 1.53906686 |
| 52 | MP0005310_abnormal_salivary_gland | 1.46551800 |
| 53 | MP0005085_abnormal_gallbladder_physiolo | 1.41764844 |
| 54 | MP0005166_decreased_susceptibility_to | 1.41190083 |
| 55 | MP0001119_abnormal_female_reproductive | 1.41033924 |
| 56 | MP0002102_abnormal_ear_morphology | 1.40728119 |
| 57 | MP0005408_hypopigmentation | 1.40458921 |
| 58 | MP0003191_abnormal_cellular_cholesterol | 1.39572089 |
| 59 | MP0000716_abnormal_immune_system | 1.37687332 |
| 60 | MP0006036_abnormal_mitochondrial_physio | 1.37343065 |
| 61 | MP0003699_abnormal_female_reproductive | 1.32396989 |
| 62 | MP0003172_abnormal_lysosome_physiology | 1.31565435 |
| 63 | MP0005464_abnormal_platelet_physiology | 1.31314909 |
| 64 | MP0002249_abnormal_larynx_morphology | 1.28735143 |
| 65 | MP0008875_abnormal_xenobiotic_pharmacok | 1.27520419 |
| 66 | MP0005395_other_phenotype | 1.23557851 |
| 67 | MP0010234_abnormal_vibrissa_follicle | 1.23301674 |
| 68 | MP0001915_intracranial_hemorrhage | 1.23077325 |
| 69 | MP0008004_abnormal_stomach_pH | 1.20969344 |
| 70 | MP0003724_increased_susceptibility_to | 1.18853269 |
| 71 | MP0009333_abnormal_splenocyte_physiolog | 1.17956435 |
| 72 | MP0001764_abnormal_homeostasis | 1.17245931 |
| 73 | MP0005319_abnormal_enzyme/_coenzyme | 1.16841047 |
| 74 | MP0005220_abnormal_exocrine_pancreas | 1.14412750 |
| 75 | MP0004947_skin_inflammation | 1.14109878 |
| 76 | MP0002277_abnormal_respiratory_mucosa | 1.12100143 |
| 77 | MP0000604_amyloidosis | 1.11728795 |
| 78 | MP0000566_synostosis | 1.10936238 |
| 79 | MP0001849_ear_inflammation | 1.10932025 |
| 80 | MP0002429_abnormal_blood_cell | 1.10052451 |
| 81 | MP0002019_abnormal_tumor_incidence | 1.09103597 |
| 82 | MP0009763_increased_sensitivity_to | 1.09037475 |
| 83 | MP0003252_abnormal_bile_duct | 1.06971342 |
| 84 | MP0006054_spinal_hemorrhage | 1.05889144 |
| 85 | MP0003448_altered_tumor_morphology | 1.05872419 |
| 86 | MP0002693_abnormal_pancreas_physiology | 1.05812058 |
| 87 | MP0008877_abnormal_DNA_methylation | 1.05804245 |
| 88 | MP0008007_abnormal_cellular_replicative | 1.05794637 |
| 89 | MP0000350_abnormal_cell_proliferation | 1.03435473 |
| 90 | MP0005332_abnormal_amino_acid | 1.03420838 |
| 91 | MP0001730_embryonic_growth_arrest | 1.02307611 |
| 92 | MP0002132_abnormal_respiratory_system | 1.00888539 |
| 93 | MP0005380_embryogenesis_phenotype | 0.99669736 |
| 94 | MP0001672_abnormal_embryogenesis/_devel | 0.99669736 |
| 95 | MP0001545_abnormal_hematopoietic_system | 0.98709930 |
| 96 | MP0005397_hematopoietic_system_phenotyp | 0.98709930 |
| 97 | MP0004019_abnormal_vitamin_homeostasis | 0.98293912 |
| 98 | MP0002998_abnormal_bone_remodeling | 0.98186197 |
| 99 | MP0004808_abnormal_hematopoietic_stem | 0.97821570 |
| 100 | MP0000653_abnormal_sex_gland | 0.96979415 |
| 101 | MP0001346_abnormal_lacrimal_gland | 0.95825117 |
| 102 | MP0005671_abnormal_response_to | 0.95818124 |
| 103 | MP0002085_abnormal_embryonic_tissue | 0.94094522 |
| 104 | MP0006035_abnormal_mitochondrial_morpho | 0.92015146 |
| 105 | MP0001697_abnormal_embryo_size | 0.91487135 |
| 106 | MP0001929_abnormal_gametogenesis | 0.91408875 |
| 107 | MP0003984_embryonic_growth_retardation | 0.90671739 |
| 108 | MP0000858_altered_metastatic_potential | 0.89602521 |
| 109 | MP0002088_abnormal_embryonic_growth/wei | 0.89265166 |
| 110 | MP0002138_abnormal_hepatobiliary_system | 0.89088584 |
| 111 | MP0001919_abnormal_reproductive_system | 0.88954168 |
| 112 | MP0010352_gastrointestinal_tract_polyps | 0.88561523 |
| 113 | MP0003453_abnormal_keratinocyte_physiol | 0.87363559 |
| 114 | MP0002210_abnormal_sex_determination | 0.87298519 |
| 115 | MP0002098_abnormal_vibrissa_morphology | 0.86624094 |
| 116 | MP0002086_abnormal_extraembryonic_tissu | 0.85907999 |
| 117 | MP0002405_respiratory_system_inflammati | 0.85250645 |
| 118 | MP0005165_increased_susceptibility_to | 0.85181465 |
| 119 | MP0000703_abnormal_thymus_morphology | 0.85136956 |
| 120 | MP0001800_abnormal_humoral_immune | 0.84797168 |
| 121 | MP0001501_abnormal_sleep_pattern | 0.84450911 |
| 122 | MP0002398_abnormal_bone_marrow | 0.83449140 |
| 123 | MP0002876_abnormal_thyroid_physiology | 0.83332630 |
| 124 | MP0009765_abnormal_xenobiotic_induced | 0.83127294 |
| 125 | MP0005647_abnormal_sex_gland | 0.82975207 |
| 126 | MP0000465_gastrointestinal_hemorrhage | 0.82908456 |
| 127 | MP0005636_abnormal_mineral_homeostasis | 0.82208701 |
| 128 | MP0010155_abnormal_intestine_physiology | 0.81439186 |
| 129 | MP0000477_abnormal_intestine_morphology | 0.79876198 |
| 130 | MP0005023_abnormal_wound_healing | 0.79182964 |
| 131 | MP0003937_abnormal_limbs/digits/tail_de | 0.77186397 |
| 132 | MP0002722_abnormal_immune_system | 0.77138392 |
| 133 | MP0005666_abnormal_adipose_tissue | 0.77013929 |
| 134 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.76653992 |
| 135 | MP0006292_abnormal_olfactory_placode | 0.76115497 |
| 136 | MP0003866_abnormal_defecation | 0.76063521 |
| 137 | MP0000613_abnormal_salivary_gland | 0.75811279 |
| 138 | MP0005167_abnormal_blood-brain_barrier | 0.75787522 |
| 139 | MP0005084_abnormal_gallbladder_morpholo | 0.75767217 |
| 140 | MP0000689_abnormal_spleen_morphology | 0.75213418 |
| 141 | MP0002090_abnormal_vision | 0.74934481 |
| 142 | MP0009643_abnormal_urine_homeostasis | 0.74338814 |
| 143 | MP0001666_abnormal_nutrient_absorption | 0.74262770 |
| 144 | MP0003566_abnormal_cell_adhesion | 0.74104507 |
| 145 | MP0000733_abnormal_muscle_development | 0.73020485 |
| 146 | MP0009278_abnormal_bone_marrow | 0.72874718 |
| 147 | MP0005410_abnormal_fertilization | 0.72063831 |
| 148 | MP0003868_abnormal_feces_composition | 0.71969217 |
| 149 | MP0009384_cardiac_valve_regurgitation | 0.71784618 |
| 150 | MP0008932_abnormal_embryonic_tissue | 0.71716903 |
| 151 | MP0000678_abnormal_parathyroid_gland | 0.70316467 |
| 152 | MP0000609_abnormal_liver_physiology | 0.70172782 |
| 153 | MP0003567_abnormal_fetal_cardiomyocyte | 0.70130756 |
| 154 | MP0002084_abnormal_developmental_patter | 0.70074332 |
| 155 | MP0004782_abnormal_surfactant_physiolog | 0.69523297 |
| 156 | MP0001851_eye_inflammation | 0.68272210 |
| 157 | MP0002163_abnormal_gland_morphology | 0.68131541 |
| 158 | MP0001853_heart_inflammation | 0.67661913 |
| 159 | MP0000767_abnormal_smooth_muscle | 0.67623513 |
| 160 | MP0001663_abnormal_digestive_system | 0.67393638 |
| 161 | MP0002006_tumorigenesis | 0.67078750 |
| 162 | MP0005076_abnormal_cell_differentiation | 0.66181146 |
| 163 | MP0003690_abnormal_glial_cell | 0.65862378 |
| 164 | MP0000598_abnormal_liver_morphology | 0.64265317 |
| 165 | MP0009250_abnormal_appendicular_skeleto | 0.63984172 |
| 166 | MP0002933_joint_inflammation | 0.62395811 |
| 167 | MP0010307_abnormal_tumor_latency | 0.59694364 |
| 168 | MP0002118_abnormal_lipid_homeostasis | 0.59642778 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.83453486 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.83453486 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 4.83453486 |
| 4 | Abnormality of macrophages (HP:0004311) | 4.17299354 |
| 5 | Male infertility (HP:0003251) | 4.06754119 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 3.59927133 |
| 7 | Abnormality of the fingertips (HP:0001211) | 3.54778783 |
| 8 | Optic neuritis (HP:0100653) | 3.50578480 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 3.50578480 |
| 10 | Stomatitis (HP:0010280) | 3.49157378 |
| 11 | Recurrent abscess formation (HP:0002722) | 3.45099143 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 3.37743237 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 3.37462981 |
| 14 | Orchitis (HP:0100796) | 3.28974892 |
| 15 | Myositis (HP:0100614) | 3.16858629 |
| 16 | Abnormality of the prostate (HP:0008775) | 3.05174129 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 2.99694075 |
| 18 | Acute necrotizing encephalopathy (HP:0006965) | 2.98576954 |
| 19 | Eczematoid dermatitis (HP:0000976) | 2.95370278 |
| 20 | Rectal prolapse (HP:0002035) | 2.92771016 |
| 21 | Obstructive lung disease (HP:0006536) | 2.90781087 |
| 22 | Chronic obstructive pulmonary disease (HP:0006510) | 2.90781087 |
| 23 | Deep venous thrombosis (HP:0002625) | 2.90707565 |
| 24 | Gastrointestinal infarctions (HP:0005244) | 2.88547678 |
| 25 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.87907625 |
| 26 | Mitochondrial inheritance (HP:0001427) | 2.84106433 |
| 27 | Increased IgM level (HP:0003496) | 2.81924582 |
| 28 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.78352354 |
| 29 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.78352354 |
| 30 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.75999716 |
| 31 | Arterial thrombosis (HP:0004420) | 2.75662421 |
| 32 | Increased cerebral lipofuscin (HP:0011813) | 2.73172955 |
| 33 | Chromsome breakage (HP:0040012) | 2.72682338 |
| 34 | Pulmonary fibrosis (HP:0002206) | 2.71941617 |
| 35 | Nausea (HP:0002018) | 2.70968975 |
| 36 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.68449081 |
| 37 | Reticulocytopenia (HP:0001896) | 2.68428761 |
| 38 | Loss of speech (HP:0002371) | 2.67090978 |
| 39 | Progressive neurologic deterioration (HP:0002344) | 2.62691227 |
| 40 | T lymphocytopenia (HP:0005403) | 2.61278310 |
| 41 | Acute encephalopathy (HP:0006846) | 2.60351036 |
| 42 | Shawl scrotum (HP:0000049) | 2.59722794 |
| 43 | Increased CSF lactate (HP:0002490) | 2.59281449 |
| 44 | Generalized aminoaciduria (HP:0002909) | 2.58642010 |
| 45 | Pulmonary embolism (HP:0002204) | 2.58128146 |
| 46 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.57603755 |
| 47 | Thrombophlebitis (HP:0004418) | 2.53586310 |
| 48 | Renal Fanconi syndrome (HP:0001994) | 2.51956489 |
| 49 | IgG deficiency (HP:0004315) | 2.51447350 |
| 50 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.49782368 |
| 51 | Ureteral stenosis (HP:0000071) | 2.47710411 |
| 52 | Lip pit (HP:0100267) | 2.47413822 |
| 53 | Amyloidosis (HP:0011034) | 2.46290634 |
| 54 | Thrombocytosis (HP:0001894) | 2.46093304 |
| 55 | Polycythemia (HP:0001901) | 2.45943291 |
| 56 | Recurrent fungal infections (HP:0002841) | 2.44587016 |
| 57 | Pulmonary infiltrates (HP:0002113) | 2.43506394 |
| 58 | Lipid accumulation in hepatocytes (HP:0006561) | 2.43305195 |
| 59 | Acute myeloid leukemia (HP:0004808) | 2.42946756 |
| 60 | Abnormality of T cell number (HP:0011839) | 2.40007189 |
| 61 | Cortical dysplasia (HP:0002539) | 2.38820721 |
| 62 | Keratoconjunctivitis sicca (HP:0001097) | 2.38653280 |
| 63 | Hepatocellular necrosis (HP:0001404) | 2.38435691 |
| 64 | Increased hepatocellular lipid droplets (HP:0006565) | 2.38131478 |
| 65 | Progressive macrocephaly (HP:0004481) | 2.36510425 |
| 66 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.32952080 |
| 67 | Meningitis (HP:0001287) | 2.32702593 |
| 68 | Hepatic necrosis (HP:0002605) | 2.31433294 |
| 69 | Polyneuropathy (HP:0001271) | 2.29005407 |
| 70 | B lymphocytopenia (HP:0010976) | 2.26180000 |
| 71 | Abnormality of B cell number (HP:0010975) | 2.25730056 |
| 72 | Cerebral edema (HP:0002181) | 2.23181226 |
| 73 | Esophageal varix (HP:0002040) | 2.23055139 |
| 74 | Hepatosplenomegaly (HP:0001433) | 2.23012380 |
| 75 | Autoimmune thrombocytopenia (HP:0001973) | 2.22112003 |
| 76 | 3-Methylglutaconic aciduria (HP:0003535) | 2.20981786 |
| 77 | Dysostosis multiplex (HP:0000943) | 2.20628971 |
| 78 | Recurrent skin infections (HP:0001581) | 2.18861085 |
| 79 | Ureteral obstruction (HP:0006000) | 2.17692050 |
| 80 | Hemoptysis (HP:0002105) | 2.17500652 |
| 81 | Birth length less than 3rd percentile (HP:0003561) | 2.17426067 |
| 82 | Increased serum ferritin (HP:0003281) | 2.16194453 |
| 83 | Premature ovarian failure (HP:0008209) | 2.15553332 |
| 84 | Multiple enchondromatosis (HP:0005701) | 2.14974685 |
| 85 | Petechiae (HP:0000967) | 2.14607224 |
| 86 | Recurrent viral infections (HP:0004429) | 2.13968855 |
| 87 | Microretrognathia (HP:0000308) | 2.13720372 |
| 88 | Gangrene (HP:0100758) | 2.13368240 |
| 89 | Anorexia (HP:0002039) | 2.12443198 |
| 90 | Hypergonadotropic hypogonadism (HP:0000815) | 2.12347672 |
| 91 | Pancreatitis (HP:0001733) | 2.10277907 |
| 92 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.09120115 |
| 93 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.08193978 |
| 94 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.08193978 |
| 95 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.08193978 |
| 96 | Patellar aplasia (HP:0006443) | 2.07892611 |
| 97 | Aplastic anemia (HP:0001915) | 2.07003557 |
| 98 | Exertional dyspnea (HP:0002875) | 2.05881348 |
| 99 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.05572690 |
| 100 | Hematochezia (HP:0002573) | 2.05216843 |
| 101 | Increased intramyocellular lipid droplets (HP:0012240) | 2.05192857 |
| 102 | Episodic fever (HP:0001954) | 2.03664374 |
| 103 | Keratoconjunctivitis (HP:0001096) | 2.03050901 |
| 104 | Lactic acidosis (HP:0003128) | 2.02878123 |
| 105 | Insulin resistance (HP:0000855) | 2.02757986 |
| 106 | Unilateral renal agenesis (HP:0000122) | 2.01682453 |
| 107 | Abnormality of the pleura (HP:0002103) | 2.01351629 |
| 108 | Disinhibition (HP:0000734) | 2.01243335 |
| 109 | Secondary amenorrhea (HP:0000869) | 2.00496236 |
| 110 | Breast hypoplasia (HP:0003187) | 2.00107802 |
| 111 | IgM deficiency (HP:0002850) | 1.99845013 |
| 112 | Malnutrition (HP:0004395) | 1.99315708 |
| 113 | Combined immunodeficiency (HP:0005387) | 1.98952162 |
| 114 | Capillary hemangiomas (HP:0005306) | 1.97937025 |
| 115 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.97241616 |
| 116 | Mutism (HP:0002300) | 1.96721318 |
| 117 | Joint swelling (HP:0001386) | 1.95959127 |
| 118 | Spontaneous abortion (HP:0005268) | 1.93514692 |
| 119 | Abnormality of T cells (HP:0002843) | 1.92355027 |
| 120 | Abnormality of the nasal mucosa (HP:0000433) | 1.91563307 |
| 121 | Purpura (HP:0000979) | 1.91335996 |
| 122 | Increased muscle lipid content (HP:0009058) | 1.90327433 |
| 123 | Abnormality of urine glucose concentration (HP:0011016) | 1.90148646 |
| 124 | Glycosuria (HP:0003076) | 1.90148646 |
| 125 | Ectopic kidney (HP:0000086) | 1.88668745 |
| 126 | Prolonged neonatal jaundice (HP:0006579) | 1.88515087 |
| 127 | Leukocytosis (HP:0001974) | 1.87553458 |
| 128 | Lethargy (HP:0001254) | 1.86980677 |
| 129 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.86288872 |
| 130 | Abnormal hemoglobin (HP:0011902) | 1.85566289 |
| 131 | Sparse lateral eyebrow (HP:0005338) | 1.85546517 |
| 132 | Respiratory failure (HP:0002878) | 1.84549697 |
| 133 | Myocardial infarction (HP:0001658) | 1.83758880 |
| 134 | Abnormality of male internal genitalia (HP:0000022) | 1.83265832 |
| 135 | Camptodactyly of toe (HP:0001836) | 1.83244480 |
| 136 | Reduced antithrombin III activity (HP:0001976) | 1.82922398 |
| 137 | Chronic diarrhea (HP:0002028) | 1.82718497 |
| 138 | Urticaria (HP:0001025) | 1.82032419 |
| 139 | Myelodysplasia (HP:0002863) | 1.81097508 |
| 140 | Lymphopenia (HP:0001888) | 1.80866286 |
| 141 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.80338067 |
| 142 | Hypochromic anemia (HP:0001931) | 1.79471406 |
| 143 | Long toe (HP:0010511) | 1.78881366 |
| 144 | Encephalitis (HP:0002383) | 1.78846635 |
| 145 | Abnormality of chromosome stability (HP:0003220) | 1.78373156 |
| 146 | Nasal polyposis (HP:0100582) | 1.78081752 |
| 147 | Facial hemangioma (HP:0000329) | 1.77386437 |
| 148 | Abnormality of the intrinsic pathway (HP:0010989) | 1.76593584 |
| 149 | Blepharitis (HP:0000498) | 1.76242376 |
| 150 | Hyperammonemia (HP:0001987) | 1.74869673 |
| 151 | Spontaneous hematomas (HP:0007420) | 1.74116382 |
| 152 | Chest pain (HP:0100749) | 1.73662547 |
| 153 | Abnormality of the intervertebral disk (HP:0005108) | 1.72312160 |
| 154 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.71319455 |
| 155 | Microcytic anemia (HP:0001935) | 1.70826739 |
| 156 | Hypoglycemic coma (HP:0001325) | 1.68421184 |
| 157 | Intrahepatic cholestasis (HP:0001406) | 1.68322765 |
| 158 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.67950551 |
| 159 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.66924000 |
| 160 | Abnormality of alanine metabolism (HP:0010916) | 1.66924000 |
| 161 | Hyperalaninemia (HP:0003348) | 1.66924000 |
| 162 | Abnormality of the preputium (HP:0100587) | 1.65523290 |
| 163 | Abnormality of methionine metabolism (HP:0010901) | 1.64283574 |
| 164 | Epistaxis (HP:0000421) | 1.63209872 |
| 165 | Vasculitis (HP:0002633) | 1.62713057 |
| 166 | Chronic bronchitis (HP:0004469) | 1.61955496 |
| 167 | Glomerulopathy (HP:0100820) | 1.61715794 |
| 168 | Abnormality of the pericardium (HP:0001697) | 1.61269251 |
| 169 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.60588147 |
| 170 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.60396573 |
| 171 | Subaortic stenosis (HP:0001682) | 1.60396573 |
| 172 | Hyperglycemia (HP:0003074) | 1.60222544 |
| 173 | Aortic dissection (HP:0002647) | 1.59730237 |
| 174 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.59291985 |
| 175 | Abnormal platelet function (HP:0011869) | 1.58248926 |
| 176 | Impaired platelet aggregation (HP:0003540) | 1.58248926 |
| 177 | Severe combined immunodeficiency (HP:0004430) | 1.56132419 |
| 178 | Rib fusion (HP:0000902) | 1.52719461 |
| 179 | Peritonitis (HP:0002586) | 1.52504292 |
| 180 | Meckel diverticulum (HP:0002245) | 1.51374021 |
| 181 | Pallor (HP:0000980) | 1.50763693 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LATS1 | 5.30575143 |
| 2 | TAOK3 | 3.73614326 |
| 3 | TXK | 3.43882511 |
| 4 | EEF2K | 3.29115471 |
| 5 | STK38L | 3.07560801 |
| 6 | LATS2 | 3.06737100 |
| 7 | MAP3K6 | 2.99066803 |
| 8 | CDK8 | 2.82097230 |
| 9 | IRAK3 | 2.56976049 |
| 10 | VRK2 | 2.54900496 |
| 11 | TESK2 | 2.48120757 |
| 12 | MATK | 2.27973758 |
| 13 | CDC7 | 2.24677763 |
| 14 | RIPK4 | 2.20919444 |
| 15 | TAOK1 | 2.17556350 |
| 16 | PLK4 | 2.12407431 |
| 17 | GRK7 | 2.10458733 |
| 18 | ADRBK2 | 2.03124905 |
| 19 | MST4 | 1.99730878 |
| 20 | BLK | 1.97434510 |
| 21 | STK3 | 1.96903678 |
| 22 | MAP3K14 | 1.93730672 |
| 23 | STK10 | 1.91185282 |
| 24 | TRIB3 | 1.88153554 |
| 25 | MAP4K1 | 1.87652847 |
| 26 | ERBB4 | 1.84436099 |
| 27 | MOS | 1.82099407 |
| 28 | IKBKB | 1.79027625 |
| 29 | MAP3K12 | 1.78807232 |
| 30 | TBK1 | 1.78624325 |
| 31 | CDK19 | 1.76221011 |
| 32 | NEK2 | 1.75724890 |
| 33 | ZAK | 1.67012640 |
| 34 | IRAK4 | 1.58123821 |
| 35 | PIM2 | 1.54503674 |
| 36 | TTK | 1.48642241 |
| 37 | RPS6KA4 | 1.44599039 |
| 38 | JAK3 | 1.42268103 |
| 39 | DMPK | 1.41329015 |
| 40 | KDR | 1.40791044 |
| 41 | KSR2 | 1.40159747 |
| 42 | NLK | 1.39921759 |
| 43 | FGR | 1.38802182 |
| 44 | CDK9 | 1.38347399 |
| 45 | MAPKAPK3 | 1.37981000 |
| 46 | TAOK2 | 1.36753015 |
| 47 | CSK | 1.36391229 |
| 48 | PKN2 | 1.35199131 |
| 49 | MAP3K13 | 1.29707644 |
| 50 | ARAF | 1.27634523 |
| 51 | ERN1 | 1.22397244 |
| 52 | ACVR1B | 1.20344754 |
| 53 | MELK | 1.18217896 |
| 54 | TLK1 | 1.15967143 |
| 55 | CDK4 | 1.15640495 |
| 56 | CHEK2 | 1.15432796 |
| 57 | BCKDK | 1.15189612 |
| 58 | MAP4K2 | 1.14244203 |
| 59 | TESK1 | 1.13410447 |
| 60 | TNK2 | 1.11017025 |
| 61 | LYN | 1.10679553 |
| 62 | VRK1 | 1.10423508 |
| 63 | TGFBR1 | 1.07252935 |
| 64 | FES | 1.04188305 |
| 65 | LRRK2 | 1.03528952 |
| 66 | CDK7 | 1.00763137 |
| 67 | DYRK3 | 0.99188047 |
| 68 | SYK | 0.98917182 |
| 69 | RPS6KB2 | 0.98477233 |
| 70 | MAPK11 | 0.97427577 |
| 71 | STK16 | 0.96549722 |
| 72 | CSF1R | 0.96373265 |
| 73 | PINK1 | 0.94889350 |
| 74 | MAP3K8 | 0.94874998 |
| 75 | RAF1 | 0.94291677 |
| 76 | HIPK2 | 0.93479585 |
| 77 | TYK2 | 0.92514893 |
| 78 | AURKB | 0.92045708 |
| 79 | MAP2K6 | 0.90677436 |
| 80 | SIK1 | 0.88186394 |
| 81 | MAP3K10 | 0.87604962 |
| 82 | CDK6 | 0.87234806 |
| 83 | MAP3K11 | 0.87046283 |
| 84 | ZAP70 | 0.83496367 |
| 85 | DAPK3 | 0.81087014 |
| 86 | PRKD2 | 0.80490475 |
| 87 | BUB1 | 0.78677553 |
| 88 | CSNK1G3 | 0.78155702 |
| 89 | LCK | 0.76333795 |
| 90 | MYLK | 0.75403288 |
| 91 | CDK12 | 0.75373640 |
| 92 | STK24 | 0.75347598 |
| 93 | NEK9 | 0.74019429 |
| 94 | TYRO3 | 0.72546750 |
| 95 | ABL2 | 0.71713204 |
| 96 | NUAK1 | 0.71074119 |
| 97 | NME2 | 0.70707243 |
| 98 | GRK1 | 0.70408924 |
| 99 | BRAF | 0.70313206 |
| 100 | MAP3K5 | 0.69993462 |
| 101 | TIE1 | 0.69849738 |
| 102 | MAP2K3 | 0.69722615 |
| 103 | TGFBR2 | 0.69716704 |
| 104 | BMPR1B | 0.69442817 |
| 105 | DAPK1 | 0.67085276 |
| 106 | PIM1 | 0.65686708 |
| 107 | SRPK1 | 0.65040719 |
| 108 | PAK4 | 0.64910983 |
| 109 | FGFR4 | 0.64690362 |
| 110 | EIF2AK3 | 0.64519436 |
| 111 | PDK2 | 0.61786186 |
| 112 | ITK | 0.60974649 |
| 113 | BMPR2 | 0.59751168 |
| 114 | TEC | 0.58968144 |
| 115 | JAK2 | 0.58770557 |
| 116 | PRKCQ | 0.58545705 |
| 117 | PRKAA2 | 0.58028956 |
| 118 | CSNK1A1L | 0.57818957 |
| 119 | OXSR1 | 0.56513550 |
| 120 | PLK1 | 0.56399951 |
| 121 | LIMK1 | 0.53670763 |
| 122 | ILK | 0.52126889 |
| 123 | DYRK2 | 0.52023939 |
| 124 | IRAK1 | 0.51414766 |
| 125 | CSNK1G2 | 0.51215793 |
| 126 | PTK6 | 0.49622485 |
| 127 | PASK | 0.49407821 |
| 128 | CHUK | 0.47952946 |
| 129 | PBK | 0.47600664 |
| 130 | STK38 | 0.47105035 |
| 131 | HCK | 0.46120856 |
| 132 | CDC42BPA | 0.45729699 |
| 133 | PRKG2 | 0.45658739 |
| 134 | GRK6 | 0.45598759 |
| 135 | MARK2 | 0.45076246 |
| 136 | MAP3K1 | 0.44020564 |
| 137 | CSNK1G1 | 0.43081497 |
| 138 | RET | 0.42554888 |
| 139 | TTN | 0.42489262 |
| 140 | RPS6KA5 | 0.41675212 |
| 141 | KIT | 0.40966326 |
| 142 | NME1 | 0.40103394 |
| 143 | MAP2K2 | 0.39675281 |
| 144 | ABL1 | 0.38708845 |
| 145 | TRPM7 | 0.38312536 |
| 146 | ATM | 0.38209614 |
| 147 | IRAK2 | 0.37831073 |
| 148 | CHEK1 | 0.37811910 |
| 149 | CSNK2A1 | 0.36545732 |
| 150 | MAP2K7 | 0.35399487 |
| 151 | DAPK2 | 0.33907433 |
| 152 | WNK3 | 0.33526145 |
| 153 | MARK3 | 0.32018395 |
| 154 | PRKAA1 | 0.31289610 |
| 155 | FLT3 | 0.30951511 |
| 156 | EPHB2 | 0.30811355 |
| 157 | PRKCD | 0.30657710 |
| 158 | MUSK | 0.30308511 |
| 159 | BTK | 0.29351078 |
| 160 | MAP3K7 | 0.27635977 |
| 161 | PRKD3 | 0.27370393 |
| 162 | IKBKE | 0.27267576 |
| 163 | ATR | 0.24064832 |
| 164 | AURKA | 0.23026704 |
| 165 | MAP3K3 | 0.22610715 |
| 166 | JAK1 | 0.21383624 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.05593033 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 2.88662131 |
| 3 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.68910189 |
| 4 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.58022116 |
| 5 | Cell cycle_Homo sapiens_hsa04110 | 2.43150541 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.32784788 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 2.31361105 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.25134914 |
| 9 | RNA degradation_Homo sapiens_hsa03018 | 2.19611137 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.06719744 |
| 11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.05219002 |
| 12 | Ribosome_Homo sapiens_hsa03010 | 1.96951234 |
| 13 | Basal transcription factors_Homo sapiens_hsa03022 | 1.85130877 |
| 14 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.79809177 |
| 15 | Parkinsons disease_Homo sapiens_hsa05012 | 1.79636127 |
| 16 | Base excision repair_Homo sapiens_hsa03410 | 1.79259661 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.72601384 |
| 18 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.68652802 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.61939380 |
| 20 | Homologous recombination_Homo sapiens_hsa03440 | 1.56170622 |
| 21 | Lysosome_Homo sapiens_hsa04142 | 1.55578438 |
| 22 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.48216346 |
| 23 | Other glycan degradation_Homo sapiens_hsa00511 | 1.47350644 |
| 24 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.46314281 |
| 25 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.40973449 |
| 26 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.40777109 |
| 27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.38432915 |
| 28 | Legionellosis_Homo sapiens_hsa05134 | 1.37549072 |
| 29 | Mismatch repair_Homo sapiens_hsa03430 | 1.36962882 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.36221051 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.36157703 |
| 32 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.35081852 |
| 33 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.34860737 |
| 34 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.34395316 |
| 35 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.32877870 |
| 36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.31531631 |
| 37 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31105076 |
| 38 | Pertussis_Homo sapiens_hsa05133 | 1.29936320 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.29546967 |
| 40 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.28866563 |
| 41 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.26391469 |
| 42 | Asthma_Homo sapiens_hsa05310 | 1.25437000 |
| 43 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.25116952 |
| 44 | Protein export_Homo sapiens_hsa03060 | 1.24797740 |
| 45 | RNA transport_Homo sapiens_hsa03013 | 1.22599824 |
| 46 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.21068390 |
| 47 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.19947153 |
| 48 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.19776873 |
| 49 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.19306039 |
| 50 | Sulfur relay system_Homo sapiens_hsa04122 | 1.18605761 |
| 51 | Adherens junction_Homo sapiens_hsa04520 | 1.18029570 |
| 52 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.16641193 |
| 53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.15961720 |
| 54 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.15507552 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.15297545 |
| 56 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.10673631 |
| 57 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.09750322 |
| 58 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.09566281 |
| 59 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.08678308 |
| 60 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.08511091 |
| 61 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.07560855 |
| 62 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.05194250 |
| 63 | Alzheimers disease_Homo sapiens_hsa05010 | 1.04173086 |
| 64 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03254927 |
| 65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.02164875 |
| 66 | Salmonella infection_Homo sapiens_hsa05132 | 1.01709766 |
| 67 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.01384240 |
| 68 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.00741634 |
| 69 | RNA polymerase_Homo sapiens_hsa03020 | 1.00174874 |
| 70 | Lysine degradation_Homo sapiens_hsa00310 | 0.99819899 |
| 71 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98351801 |
| 72 | Thyroid cancer_Homo sapiens_hsa05216 | 0.98168239 |
| 73 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.97749897 |
| 74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.97544613 |
| 75 | Malaria_Homo sapiens_hsa05144 | 0.96412236 |
| 76 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.96231202 |
| 77 | Phagosome_Homo sapiens_hsa04145 | 0.95767106 |
| 78 | Bladder cancer_Homo sapiens_hsa05219 | 0.95699614 |
| 79 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.94520564 |
| 80 | Influenza A_Homo sapiens_hsa05164 | 0.93547279 |
| 81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.93189282 |
| 82 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.93102011 |
| 83 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.90866554 |
| 84 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.90067822 |
| 85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.89678165 |
| 86 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.89268161 |
| 87 | Huntingtons disease_Homo sapiens_hsa05016 | 0.89261352 |
| 88 | Allograft rejection_Homo sapiens_hsa05330 | 0.89005550 |
| 89 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.88939573 |
| 90 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.85423729 |
| 91 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.82537861 |
| 92 | Circadian rhythm_Homo sapiens_hsa04710 | 0.82190442 |
| 93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.82015628 |
| 94 | HTLV-I infection_Homo sapiens_hsa05166 | 0.81753695 |
| 95 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.81384917 |
| 96 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.77899010 |
| 97 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.76884419 |
| 98 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.76595669 |
| 99 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.76365997 |
| 100 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.75601867 |
| 101 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.75385525 |
| 102 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.74096373 |
| 103 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.73933449 |
| 104 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.73659969 |
| 105 | Prostate cancer_Homo sapiens_hsa05215 | 0.72411873 |
| 106 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.72367071 |
| 107 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.71963632 |
| 108 | Colorectal cancer_Homo sapiens_hsa05210 | 0.71841368 |
| 109 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69946766 |
| 110 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.68792664 |
| 111 | Hepatitis B_Homo sapiens_hsa05161 | 0.67082239 |
| 112 | Galactose metabolism_Homo sapiens_hsa00052 | 0.66596917 |
| 113 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.65743063 |
| 114 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.65462713 |
| 115 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.65335709 |
| 116 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.64083240 |
| 117 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.63684040 |
| 118 | Spliceosome_Homo sapiens_hsa03040 | 0.63265453 |
| 119 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.63058981 |
| 120 | Measles_Homo sapiens_hsa05162 | 0.62843682 |
| 121 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.61993097 |
| 122 | Shigellosis_Homo sapiens_hsa05131 | 0.61064180 |
| 123 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.60959865 |
| 124 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.60811811 |
| 125 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.60380388 |
| 126 | Leishmaniasis_Homo sapiens_hsa05140 | 0.59952536 |
| 127 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.59840065 |
| 128 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.57347082 |
| 129 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.57186580 |
| 130 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56054866 |
| 131 | Peroxisome_Homo sapiens_hsa04146 | 0.56034138 |
| 132 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55562062 |
| 133 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.55401757 |
| 134 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54688902 |
| 135 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.54056621 |
| 136 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.53742702 |
| 137 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53584128 |
| 138 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53354341 |
| 139 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.52871374 |
| 140 | Retinol metabolism_Homo sapiens_hsa00830 | 0.51591297 |
| 141 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.49956119 |
| 142 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.49868855 |
| 143 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.48532729 |
| 144 | Histidine metabolism_Homo sapiens_hsa00340 | 0.48198861 |
| 145 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48058707 |
| 146 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.47436875 |
| 147 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46135858 |
| 148 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.45887182 |
| 149 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45180995 |
| 150 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44056929 |
| 151 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.43818512 |
| 152 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43774223 |
| 153 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.43140871 |
| 154 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42929963 |
| 155 | Mineral absorption_Homo sapiens_hsa04978 | 0.41544470 |
| 156 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.39514749 |
| 157 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.36986607 |
| 158 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.35564247 |
| 159 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.34883209 |

